Towa PharmaceuticalTOWA PHARMACEUTICAL CO.,LTD.4553東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Towa Pharmaceutical FY ending Mar 2020 results

Towa Pharmaceutical brought in ¥110.4B in revenue.

Out of every ¥100 of sales, about ¥15 is left as operating profit.

Where the money goes

For every ¥100 Towa Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 45.9% → Operating margin 14.6% → Net margin 13.1%

Show source documents (3)

EDINET (FSA Japan)
訂正有価証券報告書－第68期(2023/04/01－2024/03/31)
ID S100U0TC2024-07-10Open
EDINET (FSA Japan)
有価証券報告書－第66期(令和3年4月1日－令和4年3月31日)
ID S100OFJU2022-06-27Open
EDINET (FSA Japan)
有価証券報告書－第65期(令和2年4月1日－令和3年3月31日)
ID S100LQXR2021-06-28Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.